PE-Backed Par Pharmaceutical Plans $700M IPO
Private equity-backed generic-drugs maker Par Pharmaceutical Holdings Inc. said on Friday that it is gearing up to launch an initial public offering, and according to IPO exchange-traded fund manager Renaissance Capital,...To view the full article, register now.
Already a subscriber? Click here to view full article